Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
EnterprisewideAdd to Basket
Electronic (Online Access)Add to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Advanced Medical Optics Medical Device Company Intelligence Report

Espicom Business Intelligence Ltd, July 2005, Pages: 52


  Description  
   Summary   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Advanced Medical Optics (AMO), based in Santa Ana, California, USA, develops, manufactures and markets ophthalmic surgical and eye care products. Established in July 2002 through a spin-off from Allergan, the company has approximately 3,000 employees, operations in about 20 countries and markets its products in approximately 60 countries worldwide. AMO has manufacturing facilities in Puerto Rico, the Netherlands, Sweden, India, China and Spain.

The company divides its business into two areas based on product type; ophthalmic surgical products, which accounted for 56% of the company’s total revenue in fiscal 2004; and eye care products, which generated the remaining 44%.

AMO owns or has the rights to surgical brands such as ReZoom, Phacoflex, Clariflex, Array, Sensar, CeeOn, Tecnis and Verisyse intraocular lenses, Sovereign and Sovereign Compact phacoemulsification systems with WhiteStar technology, Amadeus II microkeratomes, Healon and Vitrax viscoelastics, and the Baerveldt glaucoma shunt. The product line was significantly expanded through the acquisition of Pfizer’s ophthalmic surgical business in June 2004 and the May 2005 acquisition of VISX.



Customers who bought this item also bought

Ophthalmic Instrumentation - Global Strategic Business Report

The Future of Ophthalmic Devices, Market Forecasts and Growth Opportunities to 2016 - The Vision Care Segment Emerges as a Key Revenue Generator

Alcon Medical Device Company Intelligence Report

Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified Portfolio

Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

Carl Zeiss Meditec Medical Device Company Intelligence Report

Medical Laser Systems - Global Strategic Business Report

The Top 40 European Distributors of Ophthalmic Diagnostic & Surgical Equipment, Instruments & Disposables

Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011

Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds